Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-048165

SVP and General Counsel sold 2,880 shares at an average $42.58 ($122,635)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2020-08-24 Option exercise +1,109 $7.80 $8,650 2,409 D
Taylor Stacy L SVP and General Counsel 2020-08-24 Option exercise +1,771 $6.55 $11,600 4,180 D
Taylor Stacy L SVP and General Counsel 2020-08-24 Sale −1,260 $42.07 $53,008 2,920 D
Taylor Stacy L SVP and General Counsel 2020-08-24 Sale −1,400 $42.92 $60,088 1,520 D
Taylor Stacy L SVP and General Counsel 2020-08-24 Sale −220 $43.36 $9,539 1,300 D
Derivatives
Taylor Stacy L SVP and General Counsel 2020-08-24 Option exercise · Stock Option (Right to Buy) −1,109 37,254 D
Taylor Stacy L SVP and General Counsel 2020-08-24 Option exercise · Stock Option (Right to Buy) −1,771 33,646 D
Open-market sales · 2,880 sh · avg $42.58 · $122,635
Loading xslF345X03/doc4.xml…